Investigational drug · Phase 2
RCZY690
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Advanced Malignant Solid Tumors.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 8, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "RCZY690"
First trial start
2026
Sep 15, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "RCZY690", any sponsor or status.
Conditions studied
As listed on its trial records.
- Advanced Malignant Solid Tumors
Approved drugs for the same conditions: Oncology
Largest trials
Live from ClinicalTrials.gov: studies naming "RCZY690" as an intervention, largest first.
- A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RCZY690 in Advanced Solid TumorsNot yet recruiting
Rongchang Pharmaceuticals Co., Ltd.Industry
NCT07806175 · 486 participants (planned) · Start Sep 15, 2026 · Primary completion Aug 15, 2028
Drug: RCZY690 Tablets; RCZY690 tables · For: Advanced Malignant Solid Tumors
Sites: Beijing, China; Hunan, China; Zhejiang, China · 8 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Advanced Malignant Solid Tumors
- SCTB41Phase 36 trials
Sinocelltech Ltd. · NHL - Non-Hodgkin's Lymphoma, NSCLC (Advanced Non-small Cell Lung Cancer), Advanced Malignant Solid Tumor
- SCTB39GPhase 22 trials
Sinocelltech Ltd. · Advanced Malignant Solid Tumor, Advanced Malignant Solid Tumors
- FC084CSAPhase 21 trial
FindCure Biosciences (ZhongShan) Co., Ltd. · Advanced Malignant Solid Tumors
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.